ABCD1 p.Ala626Thr
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 17609205
[PubMed]
Hillebrand M et al: "Live cell FRET microscopy: homo- and heterodimerization of two human peroxisomal ABC transporters, the adrenoleukodystrophy protein (ALDP, ABCD1) and PMP70 (ABCD3)."
No.
Sentence
Comment
244
They transfected fibroblasts from an X-ALD patient (A626T) with an ALDP construct carrying a myc epitope replacing amino acids 693-745.
X
ABCD1 p.Ala626Thr 17609205:244:52
status: NEW242 They transfected fibroblasts from an X-ALD patient (A626T) with an ALDP construct carrying a myc epitope replacing amino acids 693-745.
X
ABCD1 p.Ala626Thr 17609205:242:52
status: NEW243 They transfected fibroblasts from an X-ALD patient (A626T) with an ALDP construct carrying a myc epitope replacing amino acids 693-745.
X
ABCD1 p.Ala626Thr 17609205:243:52
status: NEW
PMID: 11748843
[PubMed]
Kemp S et al: "ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations."
No.
Sentence
Comment
174
P560S 7 1678C>T n.d. # P560L 7 1679C>T Reduced P560L 7 1679C>T Reduced fs I588 7 1765delC n.d. # R591P 7 1772G>C Absent S606L 8 1817C>T Present E609K 8 1825G>A Absent E609K 8 1825G>A Absent R617C 8 1849C>T Absent R617H 8 1850G>A Absent R617H 8 1850G>A Absent A626T 9 1876G>A Absent A626T 9 1876G>A Absent A626D 9 1877C>A n.d. # E630G 9 1889A>G n.d. # C631Y 9 1892G>A n.d. # T632I 9 1895C>T n.d. # V635M 9 1903G>A n.d. # L654P 9 1961T>C Absent # R660W 9 1978C>T Absent fs L663 9 1988insT n.d. # fs L663 IVS 9 IVS9+1g>a n.d. # fs L663 IVS 9 IVS9-1g>a n.d. # H667D 10 1999C>G Absent # T668I 10 2003C>T Absent # T693M 10 2078C>T Present # exon1-5del 1-5 n.d. # The 47 mutations marked with a # are novel unique mutations reported for the first time in this paper.
X
ABCD1 p.Ala626Thr 11748843:174:259
status: NEWX
ABCD1 p.Ala626Thr 11748843:174:282
status: NEW
PMID: 10196381
[PubMed]
Netik A et al: "Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy."
No.
Sentence
Comment
28
To investigate the influence of expression of ALDP and ALDRP on β-oxidation in an ALDP/ALDRP-deficient system, we used SV40-transformed skin fibroblasts from an X-ALD patient with the missense mutation A626T, which lack the punctate immunoreactive staining pattern characteristic for ALDP (23).
X
ABCD1 p.Ala626Thr 10196381:28:207
status: NEW113 11 with mutation A626T in ref.
X
ABCD1 p.Ala626Thr 10196381:113:17
status: NEW112 11 with mutation A626T in ref.
X
ABCD1 p.Ala626Thr 10196381:112:17
status: NEW29 To investigate the influence of expression of ALDP and ALDRP on b2;-oxidation in an ALDP/ALDRP-deficient system, we used SV40-transformed skin fibroblasts from an X-ALD patient with the missense mutation A626T, which lack the punctate immunoreactive staining pattern characteristic for ALDP (23).
X
ABCD1 p.Ala626Thr 10196381:29:207
status: NEW
PMID: 11063720
[PubMed]
Unterrainer G et al: "Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy."
No.
Sentence
Comment
43
In accordance with these data, transient transfection of ALDP-deficient fibroblasts (A626T) with normal ALD cDNA resulted in restoration of β- oxidation.
X
ABCD1 p.Ala626Thr 11063720:43:85
status: NEW51 Transient transfection of normal ALD cDNA into X-ALD fibroblast cell lines: A626T lack detectable ALDP, whereas N148S, D194H and S312C cell lines produce stable, mutated ALDP.
X
ABCD1 p.Ala626Thr 11063720:51:76
status: NEW162 SV40-transformed X-ALD fibroblasts lacking ALDP (mutation A626T) were kindly provided by Drs Smith and Braiterman (Baltimore, MD) (32).
X
ABCD1 p.Ala626Thr 11063720:162:58
status: NEW
PMID: 21700483
[PubMed]
Wang Y et al: "X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism."
No.
Sentence
Comment
90
Previously reported (Yes/No) Number of pedigrees reporteda CpG (Yes/No) 25 c.124delC ND No 1 N/A 5 c.279_280ins12bp (p.Leu93_Leu94insGluThrGlyLeu) ND No 1 No 6 c.410G>A (p.Trp137X) ND No 1 No 7 c.412_414delCTC (p.Leu139del) ND Yes 2 No 26 c.476del24 ND No 1 N/A 4 c.593C>G (p.Thr198Met) N/A No 1 Yes 8 c.695_696insG (p.Ala233fsX67) ND No 1 Yes 2 c.725G>A (p.Trp242X) Gonosomal No 1 No c.796G>A (p.Gly266Arg) ND Yes 23 Yes 27 c.797G>A (p.Gly266Gln) ND No 1 No 12 c.944C>A (p.Ser315X) ND No 1 Yes 13 c.1201C>T (p.Arg401Trp) ND Yes 12 Yes 14 c.1225-2A>G (splice defect) ND No 1 No 15 c.1390C>T (p.Arg464X) ND Yes 11 Yes 16 c.1553G>A (p.Arg518 Gln) ND Yes 20 Yes 17 c.1567C>T (p.Leu523Phe) ND No 1 No 18 c.1609C>T (p.Gln537X) ND No 1 No 28 c.1619T>G (p.Phe540Cys) ND No 1 No 19 c.1679C>T (p.Pro560Leu) ND Yes 20 Yes 29 c.1679C>T (p.Pro560Leu) ND Yes 20 Yes 20 exon3 to exon10 deletion ND Yesb 9 N/A 30 c.1781-1G>A ND No 1 No 21 c.1816T>C (p.Ser606Pro) ND Yes 3 No 31 c.1850G>A (p.Arg617His) ND Yes 20 Yes 22 c.1876G>A (p.Ala626Thr) ND Yes 10 Yes 23 c.1894A>C (p.Thr632Pro) ND No 2 No 1 c.1899C>A (p.Ser633Arg) Gonosomal Yes 2 Yes 24 c.1918 G>A (p.Glu640Lys) ND No 2 No 3 c.2030G>A (p.Gly677Asp) Gonadal No 1 Yes de novo mutation in male index case with childhood cerebral X-ALD;somatic and/or gonadal mosaicisim; de novo mutationND = none detected; N/A = not applicable; Color codes: in female carrier.
X
ABCD1 p.Ala626Thr 21700483:90:1017
status: NEW
PMID: 11438993
[PubMed]
Dvorakova L et al: "Eight novel ABCD1 gene mutations and three polymorphisms in patients with X-linked adrenoleukodystrophy: The first polymorphism causing an amino acid exchange."
No.
Sentence
Comment
69
Cell Lines and Cell Culture SV40 transformed ALDP-deficient fibroblasts from a patient (mutation A626T) were kindly provided by Dr. K.D. Smith and Dr. L.T. Braiterman (Baltimore, MD; patient 11 in Watkins et al. [1995]).
X
ABCD1 p.Ala626Thr 11438993:69:97
status: NEW
PMID: 7668254
[PubMed]
Watkins PA et al: "Altered expression of ALDP in X-linked adrenoleukodystrophy."
No.
Sentence
Comment
176
In 11 patients, missense mutations that occurred throughout the protein were found: within the transmembrane domains (patients 1, 3, and 4), within the ATP-binding domain (patients 8-12), and on either side of the ATP-binding Table 3 Mutational Analysis of the ALD Gene in IS Unrelated Patients ALDP Patient Phenotype Mutation Consequence Immunoreactivity 1 .................. CALD 825 A-GG K276E + 2.................. AMN 870-2AGAGE291,& 3 .................. CALD 872 G-C E291D 4 .................. AMN 1023 T-IC S342P+ 5 .................. AMN 1166 G-C R389H + 6 .................. CALD 1201 G-AA R401Q + 7 ........ CALD 1415-6 AAG FS@472 8 ........ AMN 1771 G-AA R591Q + 9 ........ Addison 1817 C-T S606L + 10 ................ AMN 1850 G-AA R617H 11 ................ CALD 1876 G-AA A626T 12 ................ Fetus 1884 G-C D629H + 13 ................ CALD 1932 C-UT Q645X 14 ................ AMN 1978 C-OT R660W 15 ........ AMN AExon7-10 Null Mutations in the ALD gene were determined, as described in Methods, in 15 of the ALD patients reported in table 2.
X
ABCD1 p.Ala626Thr 7668254:176:788
status: NEW178 In 11 patients, missense mutations that occurred throughout the protein were found: within the transmembrane domains (patients 1, 3, and 4), within the ATP-binding domain (patients 8-12), and on either side of the ATP-binding Table 3 Mutational Analysis of the ALD Gene in IS Unrelated Patients ALDP Patient Phenotype Mutation Consequence Immunoreactivity 1 .................. CALD 825 A-GG K276E + 2 .................. AMN 870-2 AGAG E291,& 3 .................. CALD 872 G-C E291D 4 .................. AMN 1023 T-IC S342P + 5 .................. AMN 1166 G-C R389H + 6 .................. CALD 1201 G-AA R401Q + 7 ........ CALD 1415-6 AAG FS@472 8 ........ AMN 1771 G-AA R591Q + 9 ........ Addison 1817 C-T S606L + 10 ................ AMN 1850 G-AA R617H 11 ................ CALD 1876 G-AA A626T 12 ................ Fetus 1884 G-C D629H + 13 ................ CALD 1932 C-UT Q645X 14 ................ AMN 1978 C-OT R660W 15 ........ AMN AExon7-10 Null Mutations in the ALD gene were determined, as described in Methods, in 15 of the ALD patients reported in table 2.
X
ABCD1 p.Ala626Thr 7668254:178:792
status: NEW
PMID: 11342107
[PubMed]
Albet S et al: "Rat adrenoleukodystrophy-related (ALDR) gene: full-length cDNA sequence and new insight in expression."
No.
Sentence
Comment
72
11 with mutation A626T), kindly provided by Dr K.D. Smith and Dr L.T. Braiterman, were transfected by electroporation.
X
ABCD1 p.Ala626Thr 11342107:72:17
status: NEW
PMID: 10227685
[PubMed]
Smith KD et al: "X-linked adrenoleukodystrophy: genes, mutations, and phenotypes."
No.
Sentence
Comment
175
Correction of C24:0 B-oxidation by ALDP Exon 10 Deletion Mutant Cell Line Normal A626T A626T A626T ; Construct none pcDNA3 pSK693myc pLB741 C24:0 nmol/hr/mg protein 0.87 0.10 0.17 0.18 Transfection Efficiency NA ND 37% 35% % Correction 53 59 Fibroblasts from an X-ALD patient (A626T) were transfected with the indicated plasmids by electroporation.
X
ABCD1 p.Ala626Thr 10227685:175:81
status: NEWX
ABCD1 p.Ala626Thr 10227685:175:87
status: NEWX
ABCD1 p.Ala626Thr 10227685:175:93
status: NEWX
ABCD1 p.Ala626Thr 10227685:175:277
status: NEW
PMID: 11992258
[PubMed]
Corzo D et al: "Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders."
No.
Sentence
Comment
83
Failure of Complementation Studies with X-ALD Fibroblasts to Correct the Defect Somatic-cell hybridization studies were performed with an ALDP immunonegative cell line derived from an individual with X-ALD and the ABCD1 mutation Nt1876GrA (A626T).
X
ABCD1 p.Ala626Thr 11992258:83:240
status: NEW